相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Marbostat-100 Defines a New Class of Potent and Selective Antiinflammatory and Antirheumatic Histone Deacetylase 6 Inhibitors
Andreas Sellmer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Analysis of the interplay between all-trans retinoic acid and histone deacetylase inhibitors in leukemic cells
Katrin Noack et al.
ARCHIVES OF TOXICOLOGY (2017)
HDAC10 as a potential therapeutic target in ovarian cancer
Muhtadi M. Islam et al.
GYNECOLOGIC ONCOLOGY (2017)
Histone deacetylase 10 structure and molecular function as a polyamine deacetylase
Yang Hai et al.
NATURE COMMUNICATIONS (2017)
Lysosomal accumulation of anticancer drugs triggers lysosomal exocytosis
Benny Zhitomirsky et al.
ONCOTARGET (2017)
Inhibitors of histone deacetylase as antitumor agents: A critical review
Mohammed Manal et al.
BIOORGANIC CHEMISTRY (2016)
Role of autophagy and lysosomal drug sequestration in acquired resistance to doxorubicin in MCF-7 cells
Baoqing Guo et al.
BMC CANCER (2016)
Inhibition of histone deacetylases in cancer therapy: lessons from leukaemia
Elena Ceccacci et al.
BRITISH JOURNAL OF CANCER (2016)
An ER-Associated Pathway Defines Endosomal Architecture for Controlled Cargo Transport
Marlieke L. M. Jongsma et al.
CELL (2016)
Lysosomes as mediators of drug resistance in cancer
Benny Zhitomirsky et al.
DRUG RESISTANCE UPDATES (2016)
The position of lysosomes within the cell determines their luminal pH
Danielle E. Johnson et al.
JOURNAL OF CELL BIOLOGY (2016)
A mechanism for overcoming P-glycoprotein-mediated drug resistance: novel combination therapy that releases stored doxorubicin from lysosomes via lysosomal permeabilization using Dp44mT or DpC
Nicole A. Seebacher et al.
CELL DEATH & DISEASE (2016)
SGO1 is involved in the DNA damage response in MYCN-amplified neuroblastoma cells
Yuko Murakami-Tonami et al.
SCIENTIFIC REPORTS (2016)
Vacuolar-ATPase-mediated intracellular sequestration of ellipticine contributes to drug resistance in neuroblastoma cells
Jan Hrabeta et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Histone Deacetylase 10 Regulates DNA Mismatch Repair and May Involve the Deacetylation of MutS Homolog 2
Rangasudhagar Radhakrishnan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Neuroblastoma: oncogenic mechanisms and therapeutic exploitation of necroptosis
S. Nicolai et al.
CELL DEATH & DISEASE (2015)
Regulated lysosomal exocytosis mediates cancer progression
Eda Machado et al.
SCIENCE ADVANCES (2015)
HDAC Family Members Intertwined in the Regulation of Autophagy: A Druggable Vulnerability in Aggressive Tumor Entities
Emily Koeneke et al.
CELLS (2015)
Phase 1 Study of Oral Abexinostat, a Histone Deacetylase Inhibitor, in Combination With Doxorubicin in Patients With Metastatic Sarcoma
Edwin Choy et al.
CANCER (2015)
Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance
Benny Zhitomirsky et al.
ONCOTARGET (2015)
Cysteine cathepsins and extracellular matrix degradation
Marko Fonovic et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2014)
Doxorubicin, DNA torsion, and chromatin dynamics
Fan Yang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2014)
ALK Mutations Confer Differential Oncogenic Activation and Sensitivity to ALK Inhibition Therapy in Neuroblastoma
Scott C. Bresler et al.
CANCER CELL (2014)
Mechanisms of neuroblastoma regression
Garrett M. Brodeur et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Histone deacetylase 10-promoted autophagy as a druggable point of interference to improve the treatment response of advanced neuroblastomas
Ina Oehme et al.
AUTOPHAGY (2013)
GDC-0941 enhances the lysosomal compartment via TFEB and primes glioblastoma cells to lysosomal membrane permeabilization and cell death
Stefanie Enzenmueller et al.
CANCER LETTERS (2013)
Combating apoptosis and multidrug resistant cancers by targeting lysosomes
Line Groth-Pedersen et al.
CANCER LETTERS (2013)
P-glycoprotein Mediates Drug Resistance via a Novel Mechanism Involving Lysosomal Sequestration
Tetsuo Yamagishi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Histone deacetylase 10 promotes autophagy-mediated cell survival
Ina Oehme et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Involvement of Lysosomal Exocytosis in the Excretion of Mesoporous Silica Nanoparticles and Enhancement of the Drug Delivery Effect by Exocytosis Inhibition
Rolando E. Yanes et al.
SMALL (2013)
Cancer drug resistance: an evolving paradigm
Caitriona Holohan et al.
NATURE REVIEWS CANCER (2013)
Phase I/II Intra-patient Dose Escalation Study of Vorinostat in Children with Relapsed Solid Tumor, Lymphoma or Leukemia
O. Witt et al.
KLINISCHE PADIATRIE (2012)
Evaluation of Different Biomarkers to Predict Individual Radiosensitivity in an Inter-Laboratory Comparison-Lessons for Future Studies
Burkhard Greve et al.
PLOS ONE (2012)
Imidazoacridinone-dependent lysosomal photodestruction: a pharmacological Trojan horse approach to eradicate multidrug-resistant cancers
Y. Adar et al.
CELL DEATH & DISEASE (2012)
Polyamine pathway inhibition as a novel therapeutic approach to treating neuroblastoma
Laura D. Gamble et al.
FRONTIERS IN ONCOLOGY (2012)
Neuroblastoma stem cells - mechanisms of chemoresistance and histonedeacetylase inhibitors
M. A. Khalil et al.
NEOPLASMA (2012)
Deconvoluting the context-dependent role for autophagy in cancer
Eileen White
NATURE REVIEWS CANCER (2012)
Histone deacetylase inhibitor (HDACI) PCI-24781 potentiates cytotoxic effects of doxorubicin in bone sarcoma cells
Cao Yang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Histone Deacetylases 9 and 10 Are Required for Homologous Recombination
Shweta Kotian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes
Marcus Bantscheff et al.
NATURE BIOTECHNOLOGY (2011)
Pretreatment Mitochondrial Priming Correlates with Clinical Response to Cytotoxic Chemotherapy
Triona Ni Chonghaile et al.
SCIENCE (2011)
HDAC6 controls autophagosome maturation essential for ubiquitin-selective quality-control autophagy
Joo-Yong Lee et al.
EMBO JOURNAL (2010)
Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A
Kyle V. Butler et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
HDAC family: What are the cancer relevant targets?
Olaf Witt et al.
CANCER LETTERS (2009)
Reversal of P-glycoprotein-Mediated Multidrug Resistance by the Murine Double Minute 2 Antagonist Nutlin-3
Martin Michaelis et al.
CANCER RESEARCH (2009)
Disrupting Polyamine Homeostasis as a Therapeutic Strategy for Neuroblastoma
Nicholas F. Evageliou et al.
CLINICAL CANCER RESEARCH (2009)
Histone Deacetylase 8 in Neuroblastoma Tumorigenesis
Ina Oehme et al.
CLINICAL CANCER RESEARCH (2009)
Induction of autophagy by spermidine promotes longevity
Tobias Eisenberg et al.
NATURE CELL BIOLOGY (2009)
Targeting DNA topoisomerase II in cancer chemotherapy
John L. Nitiss
NATURE REVIEWS CANCER (2009)
Class II histone deacetylases play pivotal roles in heat shock protein 90-mediated proteasomal degradation of vascular endothelial growth factor receptors
Jung-Hyun Park et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
ODC1 Is a Critical Determinant of MYCN Oncogenesis and a Therapeutic Target in Neuroblastoma
Michael D. Hogarty et al.
CANCER RESEARCH (2008)
The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men
Xiang-Jiao Yang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
HDAC6 at the intersection of autophagy, the ubiquitin-proteasome system and neurodegeneration
Udai Bhan Pandey et al.
AUTOPHAGY (2007)
Anticancer activities of histone deacetylase inhibitors
Jessica E. Bolden et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial
F Berthold et al.
LANCET ONCOLOGY (2005)
Intracellular drug sequestration events associated with the emergence of multidrug resistance: A mechanistic review
M Duvvuri et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2005)
The small chemical vacuolin-1 inhibits Ca2+-dependent lysosomal exocytosis but not cell resealing
J Cerny et al.
EMBO REPORTS (2004)
New developments in automated cytogenetic imaging: unattended scoring of dicentric chromosomes, micronuclei, single cell gel electrophoresis, and fluorescence signals
C Schunck et al.
CYTOGENETIC AND GENOME RESEARCH (2004)
The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress
Y Kawaguchi et al.
CELL (2003)
Histone deacetylases (HDACs): characterization of the classical HDAC family
AJM De Ruijter et al.
BIOCHEMICAL JOURNAL (2003)
Neuroblastoma: Biological insights into a clinical enigma
GM Brodeur
NATURE REVIEWS CANCER (2003)
Inhibitors of vacuolar H+-ATPase impair the preferential accumulation of daunomycin in lysosomes and reverse the resistance to anthracyclines in drug-resistant renal epithelial cells
Z Ouar et al.
BIOCHEMICAL JOURNAL (2003)
DNA repair capacity after γ-irradiation and expression profiles of DNA repair genes in resting and proliferating human peripheral blood lymphocytes
C Mayer et al.
DNA REPAIR (2002)
Multidrug resistance in cancer: Role of ATP-dependent transporters
MM Gottesman et al.
NATURE REVIEWS CANCER (2002)
Intracellular P-gp contributes to functional drug efflux and resistance in acute myeloid leukaemia
P Ferrao et al.
LEUKEMIA RESEARCH (2001)
Regulated secretion of conventional lysosomes
NW Andrews
TRENDS IN CELL BIOLOGY (2000)
分享论文
